Belite Bio, Inc (BLTE) Receivables - Other (2022 - 2025)

Belite Bio (BLTE) has reported Receivables - Other for 4 consecutive years, with $700000.0 the latest figure, recorded in Q4 2025.

• In Q4 2025, Receivables - Other rose 21.74% year-over-year to $700000.0; the TTM figure through Dec 2025 stood at $700000.0 (up 21.74% YoY), while the FY2025 annual figure was $700000.0, up 21.74% from the prior year.
• Receivables - Other came in at $700000.0 for Q4 2025 at Belite Bio, up from $6000.0 in the prior quarter.
• The five-year high for Receivables - Other was $818000.0 in Q4 2023, with the low at $2000.0 in Q4 2022.
• Average Receivables - Other over 4 years is $353166.7, with a median of $296500.0 recorded in 2024.
• Across the five-year window, Receivables - Other surged 40800.0% in 2023 and tumbled 66.67% in 2025, its largest moves.
• Year by year, Receivables - Other stood at $2000.0 in 2022, then soared by 40800.0% to $818000.0 in 2023, then decreased by 29.71% to $575000.0 in 2024, then increased by 21.74% to $700000.0 in 2025.
• According to Business Quant data, Receivables - Other over the past three periods registered $700000.0, $6000.0, and $575000.0 for Q4 2025, Q3 2025, and Q4 2024 respectively.